Monash IVF Group Limited logo

Monash IVF Group Limited (MVF)

Market Closed
ASX ASX
- Market Cap
- P/E Ratio
0.1% Div Yield
659,214 Volume
0.08 Eps
Want to track MVF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MVF pays dividends to its shareholders, with the most recent payment made on Apr 10, 2026. The next estimated payment will be in In 9 months on Apr 10, 2027 for a total of A$0.012.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Monash IVF Group Limited has completed 1 stock splits, with the recent split occurring on Apr 28, 2020.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ASX (AUD).

Monash IVF Group Limited (MVF) FAQ

On which exchange is it traded?

Monash IVF Group Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is MVF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.1%.

What is its market cap?

As of today, no market cap data is available.

Has Monash IVF Group Limited ever had a stock split?

Monash IVF Group Limited had 1 splits and the recent split was on Apr 28, 2020.

Monash IVF Group Limited Profile

Professional Services Industry
Industrials Sector
Dr. Richard Charles Henshaw M.D. CEO
ASX Exchange
Q6328D105 CUSIP
US Country
892 Employees
4 Mar 2026 Last Dividend
28 Apr 2020 Last Split
- IPO Date

Overview

Monash IVF Group Limited is a distinguished healthcare provider specializing in assisted reproductive technologies and specialist women imaging services, with operations spanning across Australia and Malaysia. Established in the year 2014 and headquartered in Cremorne, Australia, the organization is committed to delivering high quality fertility treatment and diagnostic services.Adopting a comprehensive approach to reproductive health, Monash IVF Group is at the forefront of offering innovative solutions and support for individuals and couples navigating the complexities of fertility issues.

Products and Services

  • Diagnostic Obstetric and Gynecological Ultrasound

    This service encompasses the use of high-frequency sound waves to create images of the internal structures of the pelvic region, including the uterus, ovaries, and early stages of pregnancy. It is instrumental in assessing and diagnosing various conditions related to women's health and pregnancy.

  • Fertility Treatment Services

    Monash IVF Group Limited provides a comprehensive range of fertility treatments, including but not limited to in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and egg-freezing services. These treatments are designed to assist individuals and couples in achieving pregnancy, offering hope to those facing challenges in conceiving naturally.

  • Tertiary Level Prenatal Diagnostic Services

    These services are focused on the early detection and diagnosis of fetal abnormalities, genetic conditions, and other pregnancy-related issues. Utilizing advanced technologies and methodologies, Monash IVF Group Limited helps to ensure the health and well-being of both the mother and the fetus during pregnancy.

  • IVF Treatment Services

    As a key component of its fertility treatment services, Monash IVF Group Limited specializes in IVF treatments, offering a highly effective solution for couples struggling with infertility. This process involves fertilizing an egg outside the body and implanting the embryo back into the womb, significantly increasing the chances of conception.

Contact Information

Address: Pelaco Building 1, Richmond, VIC, Australia, 3121
Phone: 61 3 9420 8235